PHILIP R. GREIPP, M.D.; JAMES A. BROWN, M.D.; HARVEY R. GRALNICK, M.D.
Coagulation abnormalities in clinical and experimental pancreatitis have been described. The release of proteolytic enzymes from the inflamed pancreas has been postulated as the cause of observed coagulation abnormalities. This report describes a patient who developed acute pancreatitis with severe coagulation abnormalities. Increased proteolytic activity was shown in the patient's serum and plasma and was associated with defibrination, accelerated use of fibrinogen, and other coagulation factors. The coagulation abnormalities improved as the proteolytic activity declined, and the pancreatitis abated.
Learn more about subscription options.
Register Now for a free account.
GREIPP PR, BROWN JA, GRALNICK HR. Defibrination in Acute Pancreatitis. Ann Intern Med. 1972;76:73-76. doi: 10.7326/0003-4819-76-1-73
Download citation file:
Published: Ann Intern Med. 1972;76(1):73-76.
Coagulopathies, Gastroenterology/Hepatology, Hematology/Oncology, Pancreatic Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only